Skip to content
Dose Brief
Menu
The shortlist

Alternatives to Coivas

Coivas sits at No. 234 in our ranking with a Brief Score of 66. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs Coivas.

Our top alternative

No. 1 here

CoreAge Rx

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Coverage
US only; restrictions by state, confirmed at intake

More providers worth weighing

No. 51 · Grade B−

EverSlim

80/100

EverSlim names its clinician and pharmacy networks, but its starting-price, shipping and cancellation promises need to be matched to the selected plan terms.

Semaglutide

Plan total requires confirmation

Advertised from $113/mo; billing term and upfront charge unconfirmed.

Full price details

Billing unconfirmed; full plan total unknown. Advertised from $113/month for compounded injection

Coverage
All 50 states and D.C. advertised; medication access and required visit format vary
Price trend
new to the tracker, no prior reading
No. 124 · Grade C

StackMD

73/100

StackMD publishes medication price ranges. The product listings leave the full cost open because the consultation fee and length of supply need confirmation.

Semaglutide

Complete cost unknown. Compounded product listings range from $125 to $225.

Coverage
Confirm clinician and pharmacy availability for your address.
Price trend
new to the tracker, no prior reading
No. 207 · Grade C

VevaRX

68/100

VEVArx publishes full quarterly charges and monthly alternatives, with renewal deadlines and pharmacy-stage refund limits.

Semaglutide

Confirm the applicable plan price

Public product display: $120 monthly or $267 upfront for three months ($89/month equivalent).

Legal page separately lists GLP-1 packages at $199 initially/$299 follow-up. Confirm which agreement applies; plans renew automatically.

Full price details

Compounded semaglutide offered; current applicable plan quote unknown because legal-page package prices differ; public monthly plan $120 or $267 upfront every three months; earlier listing: From $189/mo (compounded)

Coverage
FAQ lists thirty-six states; terms describe a fifty-state US-only service scope. Confirm medication-specific eligibility rather than treating the broader statement as guaranteed all-state access.
Price trend
new to the tracker, no prior reading
No. 11 · Grade B+

Ondra Health

87/100

Compounded injections with several pharmacy options, $149/$219 monthly plans and lower annual rates that require full prepayment.

Semaglutide

$149/mo

Annual option: $1,149 upfront; availability varies.

Full price details

$149/month; $1,149 prepaid for 12 months (about $96/month)

Coverage
Provider network across all 50 states; pharmacy and plan options vary by location
Price trend
new to the tracker, no prior reading
No. 54 · Grade B−

Independent Wellness

80/100

Independent Wellness pairs a named nurse practitioner with GLP-1 plans, but monthly labels and four-week delivery need checking.

Semaglutide

Confirm the billing interval

Advertises $99 first month, then $199 monthly. Monthly delivery and four-week descriptions differ; confirm supplied quantity and charge dates.

Full price details

Compounded semaglutide offered; complete current billing-period quote unknown; $99 first month then advertised $199 monthly; earlier listing: From $249/mo (all doses, compounded)

Coverage
Selected states subject to provider and pharmacy eligibility; published state counts differ
Price trend
new to the tracker, no prior reading
No. 178 · Grade C

Luma Health Co

69/100

Luma lists dose-specific four-week medication prices and no subscription, but the complete cost of care needs confirmation.

Semaglutide

Confirm medication + care total

Four-week medication listing starts at $115 and rises with dose. Formulation, route and additional care charges need confirmation.

Full price details

Current formulation and complete care quote unknown; four-week medication prices start at $115; earlier listing: From $120/mo (plus a separate fee, compounded)

Coverage
Lists selected states and DC; confirm eligibility in the jurisdiction where you receive care
Price trend
new to the tracker, no prior reading
No. 6 · Grade B

HealthRX

86/100

Compounded injectable GLP-1 care with visible plan tables, but conflicting prices and supply-versus-billing periods that need checking before payment.

Semaglutide

$165/mo on renewal

Subscribe & Save, after $149 first month.

Prepaid option: $1,163 for 48 weeks; renews every 12 months.

Full price details

$149 first month, then $165/month on Subscribe & Save; product table also shows $1,163 prepaid for 48 weeks, renewing every 12 months

Coverage
All 50 states
Price trend
new to the tracker, no prior reading
No. 18 · Grade B

NiceRx

86/100

Published compound-plan totals with four-week billing and a strict renewal-cancellation deadline.

Semaglutide

$149 / 4 weeks

12-week option: $299 upfront; billed and shipped every 12 weeks.

Full price details

$149 every 4 weeks; $299 prepaid for 12 weeks

Coverage
Confirm product availability in your state
Price trend
new to the tracker, no prior reading

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.